An Investigation of a New Laryngeal Mask Airway LMA Protector

• Register: ClinicalTrials.gov
• Last refreshed on: 14 March 2016
• Main ID: NCT02531256
• Date of registration: 21/08/2015
• Prospective Registration: No
• Primary sponsor: KK Women's and Children's Hospital
• Public title: An Investigation of a New Laryngeal Mask Airway LMA Protector LMA
• Scientific title: An Investigation of a New Laryngeal Mask Airway LMA Protector
• Date of first enrolment: January 2014
• Target sample size: 40
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT02531256
• Study type: Interventional
• Study design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: N/A

Countries of recruitment

Singapore

Contacts

• Name: Ban L Sng, FANZCA
• Affiliation: KK Women's and Children's Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- planned elective surgery with indication for LMA use

Exclusion Criteria:

- body mass index of 30 or more, known gastro-oesophageal reflux, patients with
increased risk of aspiration, upper airway pathology and mouth opening of less than 2
cm



Age minimum: 21 Years
Age maximum: 70 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Airway Morbidity

Intervention(s)

Device: LMA Protector

Primary Outcome(s)

Number of insertion attempts [Time Frame: 5 minutes]

Secondary Outcome(s)

Oropharyngeal Leak Pressure [Time Frame: 5 minutes]

Secondary ID(s)

2013/709/D

Source(s) of Monetary Support

Please refer to primary and secondary sponsors